Treatment Options for EGFR T790M Negative Acquired Resistance [360p]
Dr. Jack West suggests that progression in T790M-negative EGFR lung cancer patients may not require a change in therapy. In this video he details what should go into the decision to modify treatment f...
Author: cancergrace
Added: 03/22/2019 (Source: Oncology Tube)
Source: Oncology Tube - March 23, 2019 Category: Cancer & Oncology Source Type: podcasts
Panel Q & A Session on Sequencing EGFR Treatments with Drs. Riely and West [360p]
Drs. Jack West and Greg Riely field questions about which treatments should EGFR lung cancer patients consider when their cancers progress.
Author: cancergrace
Added: 03/22/2019 (Source: Oncology Tube)
Source: Oncology Tube - March 23, 2019 Category: Cancer & Oncology Source Type: podcasts
Access & Assistance for ALK+, ROS1 & EGFR Patients [360p]
Brendan Bietry of the Patient Advocate Foundation discusses the financial assistance programs available to lung cancer patients who receive targeted therapies.
Author: cancergrace
Added: 03/15/2019 (Source: Oncology Tube)
Source: Oncology Tube - March 16, 2019 Category: Cancer & Oncology Source Type: podcasts
Immunotherapy for Lung Cancer [360p]
Dr. Julie Brahmer, Johns Hopkins University, discusses immunotherapies for NSCLC and SCLC, analyzes the relevant trial data and addresses the unique side effects of these therapies.
Author: cancergrace
Added: 03/15/2019 (Source: Oncology Tube)
Source: Oncology Tube - March 15, 2019 Category: Cancer & Oncology Source Type: podcasts
Immunotherapy Biomarkers and Patient Selection [360p]
Dr. Julie Brahmer, Johns Hopkins University, discusses the use of biomarker testing and mutational burden to select patients for specific immunotherapies in lung cancer, renal cell carcinoma and melan...
Author: cancergrace
Added: 03/15/2019 (Source: Oncology Tube)
Source: Oncology Tube - March 15, 2019 Category: Cancer & Oncology Source Type: podcasts
Second Line Chemotherapy Options for SCLC [360p]
Dr. Cathy Pietanza from Memorial Sloan Kettering Cancer Center discusses standard chemotherapy options for treatment of both sensitive and refractory small cell lung cancer (SCLC).
Author: cancergrace
Added: 03/14/2019 (Source: Oncology Tube)
Source: Oncology Tube - March 15, 2019 Category: Cancer & Oncology Source Type: podcasts
Immunotherapy for Small Cell Lung Cancer [360p]
Dr. Cathy Pietanza from Memorial Sloan Kettering Cancer Center reviews early trial data of immunotherapy agents for treatment of small cell lung cancer (SCLC).
Author: cancergrace
Added: 03/14/2019 (Source: Oncology Tube)
Source: Oncology Tube - March 15, 2019 Category: Cancer & Oncology Source Type: podcasts
Different Lung Cancer Subtypes - Histology [360p]
Dr. Edward S. Kim from the Levine Cancer Institute in Charlotte, NC defines the concept of cancer histology and gives examples of several lung cancer subtypes.
Author: cancergrace
Added: 03/14/2019 (Source: Oncology Tube)
Source: Oncology Tube - March 15, 2019 Category: Cancer & Oncology Source Type: podcasts
Anjali Saqi, MD, MBA and Geoffrey R. Oxnard, MD - Navigating the Complexities of Molecular Testing for EGFR Mutations to Guide Treatment Selection in Lung Cancer: Evidence, Practicalities, and Implications for Pathologists
Navigating the Complexities of Molecular Testing for EGFR Mutations to Guide Treatment Selection in Lung Cancer: Evidence, Practicalities, and Implications for Pathologists (Source: PeerView CME/CE Audio Podcast - Oncology)
Source: PeerView CME/CE Audio Podcast - Oncology - March 4, 2019 Category: Cancer & Oncology Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: podcasts
Edward B. Garon, MD, MS - Improving Patient Outcomes With Cancer Immunotherapies Throughout the Lung Cancer Continuum: State of the Science and Implications for Practice
Improving Patient Outcomes With Cancer Immunotherapies Throughout the Lung Cancer Continuum: State of the Science and Implications for Practice (Source: PeerView CME/CE Audio Podcast - Oncology)
Source: PeerView CME/CE Audio Podcast - Oncology - March 4, 2019 Category: Cancer & Oncology Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: podcasts
Lung Cancer (With Focus On Elderly)
Edward B. Garon, M.D., MS Associate Clinical Professor, Director Of Thoracic Oncology Program, David Geffen School Of Medicine At UCLA, Director Of Signal Transduction And Therapeutics, Jonsson Compre...
Author: moasc
Added: 03/01/2019 (Source: Oncology Tube)
Source: Oncology Tube - March 1, 2019 Category: Cancer & Oncology Source Type: podcasts
JAMA Oncology : Integration of Stereotactic Ablative Radiotherapy Plus Surgery for Early-Stage Non –Small Cell Lung Cancer
Interview with David A. Palma, MD, PhD, author of Measuring the Integration of Stereotactic Ablative Radiotherapy Plus Surgery for Early-Stage Non–Small Cell Lung Cancer: A Phase 2 Clinical Trial (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - February 21, 2019 Category: General Medicine Source Type: podcasts
Naiyer Rizvi, MD - The Evolving Role of Immunotherapy as a Component of Multimodal Therapy in Earlier Stages of Lung Cancer: Rationale, Current Evidence, Key Trials, and Implications for Multidisciplinary Care
The Evolving Role of Immunotherapy as a Component of Multimodal Therapy in Earlier Stages of Lung Cancer: Rationale, Current Evidence, Key Trials, and Implications for Multidisciplinary Care (Source: PeerView CME/CE Audio Podcast - Oncology)
Source: PeerView CME/CE Audio Podcast - Oncology - February 7, 2019 Category: Cancer & Oncology Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: podcasts
Can Serum Tumor Markers Be Used in the Management of Lung Cancer_ [360p]
Dr. Edward S. Kim from the Levine Cancer Institute in Charlotte, NC describes the use of serum tumor markers in various types of cancer, and the lack of a useful serum tumor marker in lung cancer.
Author: cancergrace
Added: 02/05/2019 (Source: Oncology Tube)
Source: Oncology Tube - February 5, 2019 Category: Cancer & Oncology Source Type: podcasts
SBRT as a Potential Alternative for Fit Patients with Early Stage Lung Cancer [360p]
Dr. Jeffrey Bradley, Radiation Oncologist at Washington University in St. Louis, provides evidence for the use of stereotactic body radiation therapy as an alternative to surgery for operable early st...
Author: cancergrace
Added: 02/05/2019 (Source: Oncology Tube)
Source: Oncology Tube - February 5, 2019 Category: Cancer & Oncology Source Type: podcasts
